The 49 references in paper V. Chumakov A., O. Pronina A., I. Kachkov A., A. Korshounov G., B. Pineguin V., I. Anan’eva I., T. Elbeik , L. Metelitsa S., A. Dorofeev E., N. Gnouchev V., S. Souchkov V., В. Чумаков А., О. Пронина А., И. Качков А., А. Коршунов Г., Б. Пинегин В., И. Ананьева И., T. Elbeik, L. Metelitsa S., А. Дорофеев Е., Н. Гнучев В., С. Сучков В. (2014) “ОСОБЕННОСТИ СУБПОПУЛЯЦИОННОЙ АРХИТЕКТОНИКИ ПЕРИФЕРИЧЕСКОЙ КРОВИ У БОЛЬНЫХ С ГЛИОБЛАСТОМАМИ: ПАТОГЕНЕТИЧЕСКАЯ И КЛИНИЧЕСКАЯ ОЦЕНКА // SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS” / spz:neicon:mimmun:y:2006:i:1:p:37-50

1
Барышников А.Ю. Моноклональные антите+ ла серии ИКО к дифференцировочным антигенам лимфоцитов человека // Гематол. трансфузиол.– 1990.– No 8.– С. 4.
(check this in PDF content)
2
Голанов А.В. Глиобластомы больших полуша+ рий головного мозга: результаты комбинированого лечения и факторы, влияющие на апоптоз // Авто+ реф. дис. ... д+ра мед. наук.+ М., 1999.
(check this in PDF content)
3
Коршунов А.Г., Сычева Р.В., Голанов А.В. Им+ муногистохимическое изучения апоптоза в глиоб+ ластомах больших полушарий головного мозга // Архив патологии.+ 1998.+N.60+ С.23+27.
(check this in PDF content)
4
Хонина НЛ., Центнер М.И., Леплина О.Ю, Тихонова М.А., Ступак В.В., Никонов С.Д., Черных Е.Р., Останин А.А. Характеристика и механизмы иммунных нарушений у больных со злокачествен+ ными опухолями головного мозга // Вопросы он+ кологии.– 2002. –Т. 48+ No2. С196+201.
(check this in PDF content)
5
Чумаков В.А., Качков И.А., Благовещенский С.В., Пронина О.А., Зубова Ю.Е., Гнучев Н.В., Куз+ нецов В.П., Сучков С.В. Типичный и атипичный варианты иммунологического ответа у больных с глиобластомой // Журнал “Цитокины и воспале+ ние” – М. – 2002. – Т.1 – No 2. – С. 83.
(check this in PDF content)
6
Чумаков В.А., Биктимиров Р.Г., Качков И.А., Пронина О.А., Гнучев Н.В., Кузнецов В.П., Голанов А.В., СучковС.В. Серологические особенности у больных с глиобластомой // Материалы III+го съез+ да нейрохирургов России. С.+П., 2002, 4+8 июня, С. 172+173.
(check this in PDF content)
7
Barber D.F., Burshtyn D.N., Faure M., Peterson M., Rajagopalan S., Renard V., Sandusky M., Stebbins C.C., Wagtmann N., Watzl C. Inhibition of natural kill+ er cell activation signals by killer cell immunoglobu+ lin+like receptors (CD158) // Immunol Rev.+ 2001.+ Vol.181+P.223+233.
(check this in PDF content)
8
Bofill M., Borthwick N.J. CD38 in health and dis+ ease // Chem Immunol.– 2000.+Vol.75.+P.218+234.
(check this in PDF content)
9
Bohbot A., Feugeas O., Cuillerot J.M., Grosse A., Rusciani I., Faradji A., Oberling F. Peripheral blood CD34+ cells: method of purification and ex vivo ex+ pansion // Nouv Rev Fr Hematol. + 1995.+Vol.37.+ P.359+365.
(check this in PDF content)
10
Boyum A., Lovhaug D., Tresland L., Nordlie E.M. Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and os+ molality // Scand J Immunol.+ 1991.+Vol.34.+P697+712.
(check this in PDF content)
11
Cabanas C., Sanchez+Madrid F. CD18 (leuko+ cyte integrin beta2 subunit) // J Biol Regul Homeost Agents.+ 1999.+Vol.13.+P.137+139.
(check this in PDF content)
12
Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., Caligiuri M.A. Human natural killer cells: a unique innate im+ munoregulatory role for the CD56(bright) subset // Blood.– 2001.+Vol.97.+P.3146+3151.
(check this in PDF content)
13
Deininger M.H., Meyermann R., Schluesener H.J. Expression and release of CD14 in astrocytic brain tu+ mors // Neuropathol (Berl).– 2003.+Vol.106.+P.271+277.
(check this in PDF content)
14
Deterre P., Berthelier V., Bauvois B., Dalloul A., Schuber F., Lund F. CD38 in T+ and B+cell func+ tions // Chem Immunol.– 2000.+Vol.75.+P.146+168.
(check this in PDF content)
15
Dix A.R., Brooks W.H., Roszman T.L., Morford L.A. Immune defects observed in patients with prima+ ry malignant brain tumors // J Neuroimmunol.– 1999.+ Vol.100.+P.216+232.
(check this in PDF content)
16
Dustin M.L., Bivona T.G., Philips M.R. Mem+ branes as messengers in T cell adhesion signaling // Nat Immunol.+ 2004.+Vol.5.+P.363+372.
(check this in PDF content)
17
Federoff S., Hao C. Origin of microglia and their regulation by astroglia // Adv Exp Med Biol.+ 1991.+ Vol.296.+P.135+142.
(check this in PDF content)
18
Fontana A., Kristensen F., Dubs R., Gemsa D., Weber E. Production of prostaglandin E and an inter+ leukin+1 like factor by cultured astrocytes and C6 glio+ ma cells // J Immunol.– 1982.+Vol.129.+P.2413+2419.
(check this in PDF content)
19
Fries G., Perneczky A., Kempski О. Glioblasto+ ma+associated circulating monocytes and the release of epidermal growth factor // J. Neurosurg.— 1996.—Vol. 85.+P. 642+647.
(check this in PDF content)
20
Hagel C., Park S.H., Puchner M.J., Stavrou D. CD44 expression and tumour cell density correlate with response to tamoxifen/carboplatin chemotherapy in glioblastomas // J Neurooncol.+ 2004.+Vol.66.+2.+P.139+ 146.
(check this in PDF content)
21
Herreman G., Godeau P., Cabane J., Acar J.F., Digeon M., Bach J.F. Circulating immuns complexes and infections endocarditis. 64 cases // Ann Med In+ terne (Paris).+ 1978.+Vol.129.+P.387+397.
(check this in PDF content)
22
Hunter C.A., Lieberman L.A., Mason N., Pepper M., Sague S.L., Tato C., Zediak V. Costimulation in re+ sistance to infection and development of immune pa+ thology: lessons from toxoplasma // Immunol Res.+ 2003.+Vol.27.+P.331+340.
(check this in PDF content)
23
Kanda T., Yokoyama T., Ohshima S., Yuasa K., Watanabe T., Suzuki T., Murata K. T+lymphocyte sub+ sets as noninvasive markers of cardiomyopathy // Clin Cardiol.+ 1990.+Vol.13.+P.617+622.
(check this in PDF content)
24
Kleihues P.,Cavenee W.K. eds. Pathology & ge+ netics of tumors of the nervous system. World Health Organisaition classification of tumours. Lyon, France: IARC Press, 2000.
(check this in PDF content)
25
Liu Y.J., Kanzler H., Soumelis V., Gilliet M. Den+ dritic cell lineage, plasticity and cross+regulation // Nat Immunol.+ 2001.+Vol.2.+P.585+589.
(check this in PDF content)
26
Lowe J., MacLennan K.A., Powe D.G., Pound J.D., Palmer J.B. Microglial cells in human brain have phenotypic characteristics related to possible function as dendritic antigen presenting cells // J Pathol.+ 1989.+ Vol.159.+P.143+149.
(check this in PDF content)
27
Makrigiannis A.P., Anderson S.K. Regulation of natural killer cell function // Cancer Biol Ther.+ 2003.+ Vol.2.+P.610+616.
(check this in PDF content)
28
Menage P., Thibault G., Lebranchu Y., Jan M., Bardos P. Deficiency of CD4+CD45RA+ lymphocytes in patients with glioblastoma multiforme // Eur J Med.+ 1992.+Vol.1.+P.362+364.
(check this in PDF content)
29
Metelitsa L.S. Flow cytometry for natural killer T cells: multi+parameter methods for multifunctional cells // Clin Immunol.+ 2004.+Vol.110.+P.267+276.
(check this in PDF content)
30
Naot D., Sionov R.V., Ish+Shalom D. CD44: structure, function, and association with the malignant process // Adv Cancer Res.+ 1997.+ Vol.71.+P.241+319.
(check this in PDF content)
31
Nicholson I.C. CD62L (L+selectin) // J. Biol. Regul Homeost Agents.+2002.+Vol.16.+P.144+146.
(check this in PDF content)
32
Resnick D.K., Resnick N.M., Welch W.C., Coo+ per D.L. Differential expressions of CD44 variants in tumors affecting the central nervous system // Mol Diagn +1999.+Vol.4.+P.219+232.
(check this in PDF content)
33
Romagnani S. Biology of human TH1 and TH2 cells // J Clin Immunol.– 1995.+Vol.15.+P.121+129.
(check this in PDF content)
34
Senner V., Sturm A., Baur I., Schrell U.H., Dis+ tel L., Paulus W. CD24 promotes invasion of glioma cells in vivo // J Neuropathol Exp Neurol.+ 1999.+ Vol.58.+P.795+802.
(check this in PDF content)
35
Sivori S., Parolini S., Marcenaro E., Castriconi R., Pende D., Millo R., Moretta A. Involvement of nat+ ural cytotoxicity receptors in human natural killer cell+ mediated lysis of neuroblastoma and glioblastoma cell lines // J Neuroimmunol.– 2000.+Vol.107.+P.220+225.
(check this in PDF content)
36
Tada M., Karita M., Yanai H., Okita K. Applica+ tion and limitation of endoscopic polypectomy in stom+ ach polyps // Nippon Naika Gakkai Zasshi.+ 1992.+ Vol.81.+P.666+672.
(check this in PDF content)
37
Takamoto T., Hori Y., Yokoyama M.M., Koga Y., Toshima H. Lymphocyte subsets in patients with dilated cardiomyopathy and perimyocarditis // J Clin Lab Immunol.+ 1986.+Vol.19.+P.113+116.
(check this in PDF content)
38
Tarazona R., DelaRosa O., Alonso C., Ostos B., Espejo J., Pena J., Solana R. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumu+ lation of effector/senescent T cells // Mech Ageing Dev.+ 2000.+Vol.121.+P.77+88.
(check this in PDF content)
39
Toba K., Koike T., Shibata A., Hashimoto S., Ta+ kahashi M., Masuko M., Azegami T., Takahashi H., Aizawa Y. Novel technique for the direct flow cytoflu+ orometric analysis of human basophils in unseparated blood and bone marrow, and the characterization of phenotype and peroxidase of human basophils // Cy+ tometry.+ 1999.+Vol.35.+P.249+259.
(check this in PDF content)
40
Turk M.J., Wolchok J.D., Guevara+Patino J.A., Goldberg S.M., Houghton A.N. Multiple pathways to tumor immunity and concomitant autoimmunity // Immunol Rev.+ 2002.+Vol.188.+P.122+135.
(check this in PDF content)
41
Tysnes B.B., Mahesparan R. Biological mecha+ nisms of glioma invasion and potential therapeutic tar+ gets // J Neurooncol.+ 2001.+Vol.53.+P.129+147.
(check this in PDF content)
42
Ware C.F. APRIL and BAFF Connect Autoim+ munity and Cancer // J.Exp.Med.+ 2000.+Vol.192.+ P.35+37.
(check this in PDF content)
43
Weller M., Kleihues P., Dichgans J., Ohgaki H. CD95 ligand: lethal weapon against malignant glioma? // Brain Pathol.+ 1998.+Vol.8.+P.285+293.
(check this in PDF content)
44
Willmann K., Dunne J.F. A flow cytometric im+ mune function assay for human peripheral blood den+ dritic cells // J Leukoc Biol.+ 2000.+Vol.67.+P.536+544.
(check this in PDF content)
45
Wintterle S., Schreiner B., Mitsdoerffer M., Schneider D., Chen L., Meyermann R., Weller M., Wiendl H. Expression of the B7+related molecule B7+ H1 by glioma cells: a potential mechanism of immune paralysis // Cancer Res.+ 2003.+Vol.63.+P.7462+7467.
(check this in PDF content)
46
Wischhusen J., Jung G., Radovanovic I., Beier C., Steinbach J.P., Rimner A., Huang H., Schulz J.B., Ohgaki H., Aguzzi A., Rammensee H.G., Weller M. Identification of CD70+mediated apoptosis of immune effector cells as a novel immune escape pathway of hu+ man glioblastoma // Cancer Res.+ 2002.+Vol.62.+ P.2592+2599.
(check this in PDF content)
47
Yasuda M., Nakano K., Yasumoto K., Tanaka Y. CD44: functional relevance to inflammation and ma+ lignancy // Histol Histopathol.+ 2002.+Vol.17.+P.945+ 950.
(check this in PDF content)
48
Yu S.Z., Zhang J.Q., Lu G.H. An immunohis+ tochemical study of Ki+67 expression of brain tumor cells and mononuclear cell subsets infiltrating these tumors // Zhonghua Bing Li Xue Za Zhi.+ 1994.+Vol. 23.+P.267+269.
(check this in PDF content)
49
Zou J.P., Morford L.A., Chougnet C., Dix A.R., Brooks A.G., Torres N., Shuman J.D., Coligan J.E., Brooks W.H., Roszman T.L., Shearer G.M. Human glio+ ma+induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and
(check this in PDF content)